نتائج البحث - "Benzodiazepine receptor"

المساهمون: Maladies et hormones du système nerveux (DHNS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, The University of Sydney, Australian Nuclear Science and Technology Organisation Australie (ANSTO), Universität Regensburg (UR)

المصدر: ISSN: 1661-6596.

مصطلحات موضوعية: TSPO, peripheral benzodiazepine receptor, potassium channels, Kv7.2/3, KCNQ2/3, GRT-X, axonal growth, gene expression, dorsal root ganglia, [SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology, [SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN], [SDV.BDD]Life Sciences [q-bio]/Development Biology, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology

Relation: info:eu-repo/semantics/altIdentifier/pmid/39000434; PUBMED: 39000434; PUBMEDCENTRAL: PMC11242890

الاتاحة: https://cnrs.hal.science/hal-04748595
https://cnrs.hal.science/hal-04748595v1/document
https://cnrs.hal.science/hal-04748595v1/file/ijms-25-07327-v2%20%281%29.pdf
https://doi.org/10.3390/ijms25137327

View record in BASE

8

Academic Journal

‘We need more support and doctors that understand the process of tapering …’: A content analysis of free‐text responses to a questionnaire on discontinuing long‐term benzodiazepine receptor agonist use

المؤلفون: Tom Lynch, Cristín Ryan, Christy Huff, D. E. Foster, Cathal Cadogan

مصطلحات موضوعية: Clinical pharmacy and pharmacy practice, Z‐drugs, questionnaire, discontinuation, behaviour, benzodiazepines, BZRA, long‐term drug use, long‐term benzodiazepine receptor agonist, BZRA support groups

Relation: 10779/rcsi.25053911.v1; https://figshare.com/articles/journal_contribution/_We_need_more_support_and_doctors_that_understand_the_process_of_tapering_A_content_analysis_of_free_text_responses_to_a_questionnaire_on_discontinuing_long_term_benzodiazepine_receptor_agonist_use/25053911

الاتاحة: https://figshare.com/articles/journal_contribution/_We_need_more_support_and_doctors_that_understand_the_process_of_tapering_A_content_analysis_of_free_text_responses_to_a_questionnaire_on_discontinuing_long_term_benzodiazepine_receptor_agonist_use/25053911

View record in BASE

9

Academic Journal

Diffusion MRI Fiber Tractography and Benzodiazepine SPECT Imaging for Assessing Neural Damage to the Language Centers in an Elderly Patient after Successful Reperfusion Therapy

المؤلفون: Tatsushi Mutoh, Yasuyuki Yoshida, Yasuko Tatewaki, Hongkun Chin, Ryota Tochinai, Junta Moroi, Tatsuya Ishikawa

المصدر: Geriatrics, Vol 9, Iss 2, p 30 (2024)

مصطلحات موضوعية: acute ischemic stroke, post-stroke aphasia, benzodiazepine receptor imaging, diffusion tensor imaging, reperfusion therapy, Geriatrics, RC952-954.6

Relation: https://www.mdpi.com/2308-3417/9/2/30; https://doaj.org/toc/2308-3417; https://doaj.org/article/8ea6c4cc6045498a8597bc3e57254199

الاتاحة: https://doi.org/10.3390/geriatrics9020030
https://doaj.org/article/8ea6c4cc6045498a8597bc3e57254199

View record in BASE

Full Text Finder

10

Academic Journal

Time course of neuroinflammation after human stroke – a pilot study using co-registered PET and MRI

المؤلفون: Lucio D’Anna, Graham Searle, Kirsten Harvey, Paul M. Matthews, Roland Veltkamp

المصدر: BMC Neurology, Vol 23, Iss 1, Pp 1-7 (2023)

مصطلحات موضوعية: Neuroinflammation, Microglia, Benzodiazepine receptor, Brain ischemia, Neurology. Diseases of the nervous system, RC346-429

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1471-2377

URL الوصول: https://doaj.org/article/6b6c5fdb59294c7c981e05cfbe140b55

View record in DOAJ

Full Text Finder

11

Dissertation/ Thesis

Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma

المؤلفون: 大島,雪乃

مصطلحات موضوعية: ベンゾジアゼピン受容体, GABA受容体, ミダゾラム, 膵腺癌, 末梢性ベンゾジアゼピン受容体, benzodiazepine receptor, GABAA receptor, midazolam, pancreatic ductal adenocarcinoma, peripheral benzodiazepine receptor

وصف الملف: application/pdf

URL الوصول: https://ndlsearch.ndl.go.jp/books/R100000039-I12911318

Degree: 博士（医学） -- 日本大学

View record in National Diet Library Digital Collections

12

Academic Journal

Adaptation and validation of the revised Patients' Attitudes towards Deprescribing (rPATD) questionnaire for benzodiazepine receptor agonists.

المؤلفون: PÃ©tein, Catherine, Spinewine, Anne, Laroche, Marie-Laure, Niquille, Anne, Henrard, SÃ©verine

المساهمون: UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - (MGD) DÃ©partement de pharmacie

المصدر: Research in social & administrative pharmacy : RSAP, Vol. 19, p. 1278-1285 (2023)

مصطلحات موضوعية: Benzodiazepine receptor agonists, Deprescribing, Older adults, Psychometric properties, Questionnaire adaptation, rPATD questionnaire

Relation: boreal:275803; http://hdl.handle.net/2078.1/275803; info:pmid/37301641; urn:EISSN:1934-8150

الاتاحة: http://hdl.handle.net/2078.1/275803
https://doi.org/10.1016/j.sapharm.2023.05.010

View record in BASE

13

Academic Journal

PET Imaging of Neuro-Inflammation with Tracers Targeting the Translocator Protein (TSPO), a Systematic Review: From Bench to Bedside

المؤلفون: Ferdinando Corica, Maria Silvia De Feo, Joana Gorica, Marko Magdi Abdou Sidrak, Miriam Conte, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, Viviana Frantellizzi

المصدر: Diagnostics; Volume 13; Issue 6; Pages: 1029

مصطلحات موضوعية: TSPO, translocator protein, PET, neuro-inflammation, peripheral benzodiazepine receptor

وصف الملف: application/pdf

Relation: Medical Imaging and Theranostics; https://dx.doi.org/10.3390/diagnostics13061029

الاتاحة: https://doi.org/10.3390/diagnostics13061029

View record in BASE

14

Academic Journal

The Comprehensive Steroidome in Complete TSPO/PBR Knockout Mice under Basal Conditions

المؤلفون: Philippe Liere, Guo-Jun Liu, Antoine Pianos, Ryan J. Middleton, Richard B. Banati, Yvette Akwa

المصدر: International Journal of Molecular Sciences; Volume 24; Issue 3; Pages: 2474

مصطلحات موضوعية: peripheral benzodiazepine receptor, PBR, translocator protein, TSPO, steroidogenesis, neurosteroids, endocrine glands, mitochondria, gas chromatography–tandem mass spectrometry, gene knockout

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Molecular Endocrinology and Metabolism; https://dx.doi.org/10.3390/ijms24032474

الاتاحة: https://doi.org/10.3390/ijms24032474

View record in BASE

15

Academic Journal

Insomnia: definition, prevalence, health risks and therapy approaches ; Бессонница: определение, распространенность, риски для здоровья и подходы к терапии

المؤلفون: N. V. Pizova, Н. В. Пизова

المصدر: Meditsinskiy sovet = Medical Council; № 3 (2023); 85-91 ; Медицинский Совет; № 3 (2023); 85-91 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: нарушения сна, benzodiazepine receptor agonists, antidepressants, antihistamines, antipsychotics, sleep disorders, агонисты бензодиазепиновых рецепторов, антидепрессанты, антигистаминные препараты, антипсихотики

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/7416/6609; Rémi J., Pollmächer T., Spiegelhalder K., Trenkwalder C., Young P. Sleep-Related Disorders in Neurology and Psychiatry. Dtsch Arztebl Int. 2019;116(41):681–688. https://doi.org/10.3238/arztebl.2019.0681.; Winkelman J.W. Clinical practice. Insomnia disorder. N Engl J Med. 2015;373(15):1437–1444. https://doi.org/10.1056/NEJMcp1412740.; Chaput J., Janssen I., Sampasa-Kanyinga H., Carney C., Dang-Vu T., Davidson J. et al. Economic burden of insomnia symptoms in Canada. Sleep Health. 2022;S2352-7218(22)00178-4. https://doi.org/10.1016/j.sleh.2022.09.010.; Ozminkowski R.J., Wang S., Walsh J.K. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep. 2007;30(3):263–273. https://doi.org/10.1093/sleep/30.3.263.; Sarsour K., Kalsekar A., Swindle R., Foley K., Walsh J. The association between insomnia severity and healthcare and productivity costs in a health plan sample. Sleep. 2011;34(4):443–450. https://doi.org/10.1093/sleep/34.4.443.; Atalay H. Comorbidity of insomnia detected by the Pittsburgh sleep quality index with anxiety, depression and personality disorders. Isr J Psychiatry Related Sci. 2011;48(1):54–59. Available at: https://pubmed.ncbi.nlm.nih.gov/21572244.; Ye Y.Y., Zhang Y.F., Chen J., Liu J., Li X.J., Liu Y.Z. et al. Internet-based cognitive behavioral therapy for insomnia (ICBT-i) improves comorbid anxiety and depression-a meta-analysis of randomized controlled trials. PLoS ONE. 2015;10(11):e0142258. https://doi.org/10.1371/journal.pone.0142258.; Taylor D.J., Lichstein K.L., Durrence H.H. Insomnia as a health risk factor. Behav Sleep Med. 2003;1(4):227–247. https://doi.org/10.1207/S15402010BSM0104_5.; Buysse D.J. Insomnia. JAMA. 2013;309(7):706–716. https://doi.org/10.1001/jama.2013.193.; Пизова Н.В., Пизов А.В., Соловьев И.Н. Бессонница: факторы риска, половозрастные особенности и подходы к терапии. Медицинский совет. 2022;16(11):62–70. https://doi.org/10.21518/2079-701X-2022-16-11-62-70.; Sateia M.J. International Classification of Sleep Disorders – third edition: highlights and modifications. Chest. 2014;146(5):1387–1394. https://doi.org/10.1378/chest.14-0970.; Pillai V., Roth T., Drake C.L. The nature of stable insomnia phenotypes. Sleep. 2015;38(1):127–138. https://doi.org/10.5665/sleep.4338.; Vgontzas A.N., Fernandez-Mendoza J., Liao D., Bixler E.O. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17(4):241–254. https://doi.org/10.1016/j.smrv.2012.09.005.; Taylor D.J., Mallory L.J., Lichstein K.L., Durrence H.H., Riedel B.W., Bush A.J. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30(2):213–218. https://doi.org/10.1093/sleep/30.2.213.; Buysse D.J., Angst J., Gamma A., Ajdacic V., Eich D., Rössler W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep. 2008;31(4):473–480. https://doi.org/10.1093/sleep/31.4.473.; Schutte-Rodin S., Broch L., Buysse D., Dorsey C., Sateia M. Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults. J Clin Sleep Med. 2008;4(5):487–504. Available at: https://pubmed.ncbi.nlm.nih.gov/18853708/.; Aernout E., Benradia I., Hazo J.-B., Sy A., Askevis-Leherpeux F., Sebbane D., Roelandt J.-L. International study of the prevalence and factors associated with insomnia in the general population. Sleep Med. 2021;(82):186–192. https://doi.org/10.1016/j.sleep.2021.03.028.; Hapke U., Maske U.E., Scheidt-Nave C., Bode L., Schlack R., Busch M.A. Chronic stress among adults in Germany: Results of the German Health Interview and Examination Survey for Adults (DEGS1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(5–6):749–754. https://doi.org/10.1007/s00103-013-1690-9.; Cho Y.W., Shin W.C., Yun C.H., Hong S.B., Kim J., Earley C.J. Epidemiology of insomnia in Korean adults: Prevalence and associated factors. J Clin Neurol. 2009;5(1):20–23. https://doi.org/10.3988/jcn.2009.5.1.20.; Entrambasaguas M., Romero O., Guevara J., Larrinaga A., Cañellas F., Salud J., Díaz H. The prevalence of insomnia in Spain: A stepwise addition of ICSD-3 diagnostic criteria and notes. Sleep Epidemiology. 2023;(3):100053. https://doi.org/10.1016/j.sleepe.2022.100053.; Hysing M., Pallesen S., Stormark K., Lundervold A., Sivertsen B. Sleep patterns and insomnia among adolescents: a population-based study. J Sleep Res. 2013;22(5):549–556. https://doi.org/10.1111/jsr.12055.; Roberts R.E., Roberts C.R., Duong H.T. Chronic Insomnia and Its Negative Consequences for Health and Functioning of Adolescents: A 12-Month Prospective Study. J Adolesc Health. 2008;42(3):294–302. https://doi.org/10.1016/j.jadohealth.2007.09.016.; Chung K.F., Kan K.K.K., Yeung W.F. Insomnia in adolescents: prevalence, help-seeking behaviors, and types of interventions. Child Adolesc Ment Health. 2014;19(1):57–63. https://doi.org/10.1111/camh.12009.; Dohnt H., Gradisar M., Short M. Insomnia and its symptoms in adolescents: comparing DSM-IV and ICSD-II diagnostic criteria. J Clin Sleep Med. 2012;8(3):295–299. https://doi.org/10.5664/jcsm.1918.; Wolfson A.R., Montgomery-Downs H.E. (edit.). The Oxford handbook of infant, child, and adolescent sleep and behavior. New York: Oxford University Press; 2013. Available at: https://www.researchgate.net/publication/257102548_Roane_BM_Taylor_DJ_Pediatric_Insomnia_Montgomery-Down_H_Wolfson_A_Oxford_Handbook_of_Infant_Child_and_Adolescent_Sleep_Development_and_Problems_2013.; Amaral M., de Almeida G.A., de Figueiredo P.C., Master N., de Rosário D.NC., Sakellarides C. Quality of life, sleepiness and depressive symptoms in adolescents with insomnia: A cross-sectional study. Aten Primaria. 2017;49(1):35–41. https://doi.org/10.1016/j.aprim.2016.03.004.; Crowley K. Sleep and sleep disorders in older adults. Neuropsychol Rev. 2011;21(1):41–53. https://doi.org/10.1007/s11065-010-9154-6.; Ohayon M.M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111. https://doi.org/10.1053/smrv.2002.0186.; Hillman D.R., Murphy A.S., Pezzullo L. The economic cost of sleep disorders. Sleep. 2006;29(3):299–305. https://doi.org/10.1093/sleep/29.3.299.; Foley D.J., Monjan A., Simonsick E.M., Wallace R.B., Blazer D.G. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. Sleep. 1999;22(Suppl 2):S366–S372. Available at: https://pubmed.ncbi.nlm.nih.gov/10394609/.; Castro C.M., Lee K., Bliwise D.L., Urizar G.G., Woodward S.H., King A.C. Sleep patterns and sleep-related factors between caregiving and non-caregiving women. Behav Sleep Med. 2009;7(3):164–179. https://doi.org/10.1080/15402000902976713.; Morgan K. Daytime activity and risk factors for late-life insomnia. J Sleep Res. 2003;12(3):231–238. https://doi.org/10.1046/j.1365-2869.2003.00355.x.; Foley D., Ancoli-Israel S., Britz P., Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res. 2004;56(5):497–502. https://doi.org/10.1016/j.jpsychores.2004.02.010.; Vitiello M.V., Moe K.E., Prinz P.N. Sleep complaints cosegregate with illness in older adults: clinical research informed by and informing epidemiological studies of sleep. J Psychosom Res. 2002;53(1):555–559. https://doi.org/10.1016/s0022-3999(02)00435-x.; Aschoff J., Fatranska M., Giedke H., Doerr P., Stamm D., Wisser H. Human circadian rhythms in continuous darkness: entrainment by social cues. Science. 1971;171(3967):213–215. https://doi.org/10.1126/science.171.3967.213.; Benloucif S., Orbeta L., Ortiz R., Janssen I., Finkel S.I., Bleiberg J., Zee P.C. Morning or evening activity improves neuropsychological performance and subjective sleep quality in older adults. Sleep. 2004;27(8):1542–1551. https://doi.org/10.1093/sleep/27.8.1542.; Naylor E., Penev P.D., Orbet L., Janssen I., Ortiz R., Colecchia E.F. et al. Daily social and physical activity increases slow wave sleep and daytime neuropsychological performance in the elderly. Sleep. 2000;23(1):87–95. https://pubmed.ncbi.nlm.nih.gov/10678469/.; McCurry S.M., Logsdon R.G., Teri L., Vitiello M.V. Evidence-based psychological treatments for insomnia in older adults. Psychol Aging. 2007;22(1):18–27. https://doi.org/10.1037/0882-7974.22.1.18.; Gordon N.P., Yao J.H., Brickner L.A., Lo J.C. Prevalence of sleep-related problems and risks in a community-dwelling older adult population: a cross-sectional survey-based study. BMC Public Health. 2022;22(1):2045. https://doi.org/10.1186/s12889-022-14443-8.; Пизова Н.В., Пизов А.В. Особенности бессонницы у мужчин и женщин в разные возрастные периоды. Медицинский совет. 2022;(21):112–118. https://doi.org/10.21518/2079-701X-2022-16-21-112-118.; Sivertsen B., Pallesen S., Friborg O., Nilsen K.B, Bakke Ø.K., Goll J.B., Hopstock L.A. Sleep patterns and insomnia in a large population-based study of middle-aged and older adults: the Tromsø study 2015–2016. J Sleep Res. 2021;30(1):е13095. https://doi.org/10.1111/JSR.13095.; Zhang J., Chan N.Y., Lam S.P., Li S.X., Liu Y., Chan J.W.Y. et al. Emergence of sex differences in insomnia symptoms in adolescents: a large-scale school-based study. Sleep. 2016;39(8):1563–1570. https://doi.org/10.5665/sleep.6022.; Zeng L.N., Zong Q.Q., Yang Y., Zhang L., Xiang Y.F., Ng C.H., Chen L.G., Xiang Y.T. Gender difference in the prevalence of insomnia: a metaanalysis of observational studies. Front Psychiatry. 2020;(11): 577429. https://doi.org/10.3389/fpsyt.2020.577429.; Lallukka T., Sares-Jäske L., Kronholm E., Sääksjärvi K., Lundqvist A., Partonen T. et al. Sociodemographic and socioeconomic differences in sleep duration and insomnia-related symptoms in Finnish adults. BMC Public Health. 2012;(12):565. https://doi.org/10.1186/1471-2458-12-565.; Murtagh K.N., Hubert B.H. Gender differences in physical disability among an elderly cohort. Am J Public Health. 2004;94(8):1406–1411. https://doi.org/10.2105/AJPH.94.8.1406.; Angst J., Gamma A., Gastpar M., Lépine J.-P., Mendlewicz J., Tylee A. Gender differences in depression. Eur Arch Psychiatry Clin Neurosci. 2002;252(5):201–209. https://doi.org/10.1007/s00406-002-0381-6.; Moieni M., Irwin M.R., Jevtic I., Olmstead R., Breen E.C., Eisenberger I.N. Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression. Neuropsychopharmacology. 2015;40(7):1709–1716. https://doi.org/10.1038/npp.2015.17.; Asher M., Aderka M.I. Gender differences in social anxiety disorder. J Clin Psychol. 2018;74(10):1730–1741. https://doi.org/10.1002/jclp.22624.; Nguyen V., George T., Brewster G.S. Insomnia in older adults. Curr Geriatr Rep. 2019;8(4):271–290. https://doi.org/10.1007/s13670-019-00300-x.; Li M., Zhang X. W., Hou W. S., Tang Z. Y. Insomnia and risk of cardiovascular disease: a meta-analysis of cohort studies. Int J Cardiol. 2014;176(3):1044–1047. https://doi.org/10.1016/j.ijcard.2014.07.284.; Meng L., Zheng Y., Hui R. The relationship of sleep duration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studies. Hypertens Res. 2013;36(11):985–995. https://doi.org/10.1038/hr.2013.70.; Sofi F., Cesari F., Casini A., Macchi C., Abbate R., Gensini G.F. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2014;21(1):57–64. https://doi.org/10.1177/2047487312460020.; Laugsand L.E., Vatten L.J., Platou C., Janszky I. Insomnia and the risk of acute myocardial infarction: a population study. Circulation. 2011;124(19):2073–2081. https://doi.org/10.1161/CIRCULATIONAHA.111.025858.; Laugsand L.E., Strand L.B., Platou C., Vatten L.J., Janszky I. Insomnia and the risk of incident heart failure: a population study. Eur Heart J. 2014;35(21):1382–1393. https://doi.org/10.1093/eurheartj/eht019.; Palagini L., Bruno R.M., Gemignani A., Baglioni C., Ghiadoni L., Riemann D. Sleep loss and hypertension: a systematic review. Curr Pharm Des. 2013;19(13):2409–2419. https://doi.org/10.2174/1381612811319130009.; Anothaisintawee T., Reutrakul S., Van Cauter E., Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis. Sleep Med Rev. 2016;(30):11–24. https://doi.org/10.1016/j.smrv.2015.10.002.; Bayon V., Léger D., Gomez-Merino N., Vecchierini M.F., Chennaoui M. Sleep debt and obesity. Ann Med. 2014;46(5):264–272. https://doi.org/10.3109/07853890.2014.931103.; Buxton O.M., Marcelli E. Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States. Soc Sci Med. 2010;71(5):1027–1036. https://doi.org/10.1016/j.socscimed.2010.05.041.; Cappuccio F.P., D’Elia L., Strazzullo P., Miller M.A. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33(2):414–420. https://doi.org/10.2337/dc09-1124.; Faraut B., Touchette E., Gamble H., Royant-Parola S., Safar M.E., Varsat B., Léger D. Short sleep duration and increased risk of hypertension: a primary care medicine investigation. J Hypertens. 2012;30(7):1354–1363. https://doi.org/10.1097/HJH.0b013e32835465e5.; Patel S.R., Hu F.B. Short sleep duration and weight gain: a systematic review. Obesity. 2008;16(3):643–653. https://doi.org/10.1038/oby.2007.118.; Liu T.Z., Xu C., Rota M., Cai H., Zhang C., Shi M.J. et al. Sleep duration and risk of all-cause mortality: a flexible, non-linear, meta-regression of 40 prospective cohort studies. Sleep Med Rev. 2017;(32):28–36. https://doi.org/10.1016/j.smrv.2016.02.005.; Mayer G., Jennu P., Riemann D., Dauvilliers Y. Insomnia in central neurologic diseases – occurrence and management. Sleep Med Rev. 2011;15(6):369–378. https://doi.org/10.1016/j.smrv.2011.01.005.; Yaffe K., Falvey C.M., Hoang T. Connections between sleep and cognition in older adults. Lancet Neurol. 2014;13(10):1017–1028. https://doi.org/10.1016/S1474-4422(14)70172-3.; Sexton C.E., Storsve A.B., Walhovd K.B., Johansen-Berg H., Fjell A.M. Poor sleep quality is associated with increased cortical atrophy in community-dwelling adults. Neurology. 2014;83(11):967–973. https://doi.org/10.1212/WNL.0000000000000774.; Osorio R.S., Pirraglia E., Agüera-Ortiz L.F., During E.H., Sacks H., Ayappa I. et al. Greater risk of Alzheimer’s disease in older adults with insomnia. J Am Geriatr Soc. 2011;59(3):559–562. https://doi.org/10.1111/j.1532-5415.2010.03288.x.; Bassetti C.L., Ferini-Strambi L., Brown S., Adamantidis A., Benedetti F., Bruni O. et al. Neurology and psychiatry: waking up to the opportunities of sleep. Eur J Neurol. 2015;22(10):1337–1354. https://doi.org/10.1111/ene.12781.; Riemann D., Voderholzer U. Primary insomnia: a risk factor to develop depression? J Affect Disord. 2003;76(1–3):255–259. https://doi.org/10.1016/s0165-0327(02)00072-1.; Baglioni C., Battagliese G., Feige B., Spiegelhalder K., Nissen C., Voderholzer U. et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135(1–3):10–19. https://doi.org/10.1016/j.jad.2011.01.011.; Paunio T., Korhonen T., Hublin C., Partinen M., Koskenvuo K., Koskenvuo M., Kaprio J. Poor sleep predicts symptoms of depression and disability retirement due to depression. J Affect Disord. 2015;(172):381–389. https://doi.org/10.1016/j.jad.2014.10.002.; Laugsand L.E., Strand L.B., Vatten L.J., Janszky I., Bjørngaard J. H. Insomnia symptoms and risk for unintentional fatal injuries – the HUNT Study. Sleep. 2014;37(11):1777–1786. https://doi.org/10.5665/sleep.4170.; Sivertsen B., Øverland S., Pallesen S., Bjorvatn B., Nordhus I.H., Maeland J.G., Mykletun A. Insomnia and long sleep duration are risk factors for later work disability. The Hordaland Health Study. J Sleep Res. 2009;18(1):122–128. https://doi.org/10.1111/j.1365-2869.2008.00697.x.; Sivertsen B., Øverland S., Bjorvatn B., Maeland J.G., Mykletun A. Does insomnia predict sick leave? The Hordaland Health Study. J Psychosom Res. 2009;66(1):67–74. https://doi.org/10.1016/j.jpsychores.2008.06.011.; Léger D., Bayon V., Ohayon M.M., Philip P., Ement P., Metlaine A. et al. Insomnia and accidents: cross sectional study (EQUINOX) on sleep-related home, work and car accidents in 5293 subjects with insomnia from ten countries. J Sleep Res. 2014;23(2):143–152. https://doi.org/10.1111/jsr.12104.; Leger D., Guilleminault C., Bader G., Levy E., Paillard M. Medical and socio-professional impact of insomnia. Sleep. 2002;25(6):625–629. https://pubmed.ncbi.nlm.nih.gov/12224841/.; Leigh J.P. Employee and job attributes as predictors of absenteeism in a national sample of workers: the importance of health and dangerous working conditions. Soc Sci Med. 1991;33(2):127–137. https://doi.org/10.1016/0277-9536(91)90173-a.; Sateia M.J., Buysse D.J., Krystal A.D., Neubauer D.N., Heald J.L. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307–349. https://doi.org/10.5664/jcsm.6470.; Qaseem A., Kansagara D., Forciea M.A., Cooke M., Denberg T.D. Clinical Guidelines Committee of the American College of Physicians. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125–133. https://doi.org/10.7326/M15-2175.; Ng L., Cunnington D. Management of insomnia in primary care. Aust Prescr. 2021;44(4):124–128. https://doi.org/10.18773/austprescr.2021.027.; Edinger J.D., Arnedt J.T., Bertisch S.M., Carney C.E., Harrington J.J., Lichstein K.L. et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255–262. https://doi.org/10.5664/jcsm.8986.; Morin C.M., Vallières A., Guay B., Ivers H., Savard J., Mérette C. et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009;301(19):2005–20015. https://doi.org/10.1001/jama.2009.682.; Hertenstein E., Trinca E., Wunderlin M., Schneider C.L., Züst M.A., Fehér K.D., Su T. et al. Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: A systematic review and meta-analysis. Sleep Med Rev. 2022;62:101597. https://doi.org/10.1016/j.smrv.2022.101597.; Schutte-Rodin S., Broch L., Buysse D., Dorsey C., Sateia M. Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults. J Clin Sleep Med. 2008;4(5):487–504. Аvailable at: https://pubmed.ncbi.nlm.nih.gov/18853708/.; Cumming R.G., Le Couteur D.G. Benzodiazepines and risk of hip fractures in older people: A review of the evidence. CNS Drugs. 2003;17(11):825–837. https://doi.org/10.2165/00023210-200317110-00004.; Puustinen J., Lähteenmäki R., Polo-Kantola P., Salo P., Vahlberg T., Lyles A. et al. Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults. Eur J Clin Pharmacol. 2014;70(3):319–329. https://doi.org/10.1007/s00228-013-1613-6.; Fluyau D., Revadigar N., Manobianco B.E. Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation. Ther Adv Psychopharmacol. 2018;8(5):147–168. https://doi.org/10.1177/2045125317753340.; Buscemi N., Vandermeer B., Friesen C., Bialy L., Tubman M., Ospina M. et al. The Efficacy and Safety of Drug Treatments for Chronic Insomnia in Adults: A Meta-analysis of RCTs. J Gen Intern Med. 2007;22(9):1335– 1350. https://doi.org/10.1007/s11606-007-0251-z.; Richter G., Liao V.W.Y., Ahring P.K., Chebib M. The Z-Drugs Zolpidem, Zaleplon, and Eszopiclone Have Varying Actions on Human GABA A Receptors Containing γ1, γ2, and γ3 Subunits. Front Neurosci. 2020;(14):599812. https://doi.org/10.3389/fnins.2020.599812.; Bouchette D., Akhondi H., Quick J. Zolpidem. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available at: https://pubmed.ncbi.nlm.nih.gov/28723037/.; Gregory A.M., Caspi A., Eley T.C., Moffitt T.E., O’Connor T.G., Poulton R. Prospective longitudinal associations between persistent sleep problems in childhood and anxiety and depression disorders in adulthood. J Abnorm Child Psychol. 2005;33(2):157–163. https://doi.org/10.1007/s10802-005-1824-0.; Ohayon M.M., Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res. 2003;37(1):9–15. https://doi.org/10.1016/S0022-3956(02)00052-3.; Espie C.A. Understanding insomnia through cognitive modelling. Sleep Med. 2007;8(4):S3–S8. https://doi.org/10.1016/S1389-9457(08)70002-9.; Neubauer D. ZolpiMistTM: a new formulation of zolpidem tartrate for the short-term treatment of insomnia in the US. Nat Sci Sleep. 2010;(2):79–84. https://doi.org/10.2147/nss.s6431.; Porwal A., Yadav Y., Pathak K., Yadav R. An Update on Assessment, Therapeutic Management, and Patents on Insomnia. Biomed Res Int. 2021;2021:6068952. https://doi.org/10.1155/2021/6068952.; Krystal A.D. A compendium of placebo-controlled trials of the risks/ benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice. Sleep Med Rev. 2009;13(4):265–274. https://doi.org/10.1016/j.smrv.2008.08.001.; Rose M., Kam C.A. Gabapentin: pharmacology and its use in pain management. Anaesthesia. 2002;57(5):451–462. https://doi.org/10.1046/j.0003-2409.2001.02399.x.; Gajraj N.M. Pregabalin: its pharmacology and use in pain management. Anesth Analg. 2007;105(6):1805–1815. https://doi.org/10.1213/01.ane.0000287643.13410.5e.; Dooley D.J., Taylor C.P., Donevan S., Feltner D. Erratum: Ca2+ channel α2δ ligands: novel modulators of neurotransmission. Trends Pharmacol Sci. 2007;28(2):75–82. https://doi.org/10.1016/j.tips.2006.12.006.; Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions. Curr Opin Anaesthesiol. 2007;20(5):456–472. https://doi.org/10.1097/ACO.0b013e3282effaa7.; de Haas S., Otte A., de Weerd A., van Erp G., Cohen A., van Gerven J. Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy. J Clin Sleep Med. 2007;3(5):473–478. https://doi.org/10.5664/jcsm.26911.; Holsboer-Trachsler E., Prieto R. Effects of pregabalin on sleep in generalized anxiety disorder. Int J Neuropsychopharmacol. 2013;16(4):925–936. https://doi.org/10.1017/S1461145712000922.; Videla S., Lahjou M., Guibord P., Xu Z., Tolrà C., Encina G. et al. Food effects on the pharmacokinetics of doxylamine hydrogen succinate 25 mg film-coated tablets: a single-dose, randomized, two-period crossover study in healthy volunteers. Drugs R D. 2012;12(4):217–225. https://doi.org/10.2165/11641640-000000000-00000.; Костюкова Е.Г. Перспективы использования доксиламина в психиатрической практике. РМЖ. 2012;20(31):1569–1572. Режим доступа: https://www.rmj.ru/articles/psikhiatriya/Perspektiva_ispolyzovaniya_doksilamina_v_psihiatricheskoy_praktike/.; Смулевич А.Б., Павлова Л.К., Железнова М.В. Применение препарата Донормил при лечении нарушений сна средней и легкой степени выраженности. РМЖ. 2006;(23):1714. Режим доступа: https://www.rmj.ru/articles/psikhiatriya/Primenenie_preparata_Donormil_pri_lechenii_narusheniy_sna_sredney_i_legkoy_stepeni_vyraghennosti/?ysclid=lebi0uymu2487096968.; Бурчаков Д.И., Тардов М.В. Инсомния в практике терапевта: роль доксиламина. Медицинский совет. 2020;(2):45–53. https://doi.org/10.21518/2079-701X-2020-2-45-53.; Романов Д.В., Юзбашян П.Г. Острая инсомния: опыт применения доксиламина. Медицинский совет. 2020;(21):267–273. https://doi.org/10.21518/2079-701X-2020-21-267-273.; Левин Я.И. Доксиламин (Донормил) в лечении инсомнии. РМЖ. 2006;(9):704. Режим доступа: https://www.rmj.ru/articles/obshchie-stati/Doksilamin_Donormil_v_lechenii_insomnii.; Смирнов А.А., Густов А.В., Желтова О.Ю. Эффективность применения донормила в лечении инсомний у больных дисциркуляторной энцефалопатией. Журнал неврологии и психиатрии им. С.С. Корсакова. 2006;(3):56–57. Режим доступа: https://www.fesmu.ru/elib/Article.aspx?id=143391.; Левин Я.И. Сон, инсомния, доксиламин (Донормил). РМЖ. 2007;(10):850–855. Режим доступа: https://www.rmj.ru/articles/nevrologiya/Son_insomniya_doksilamin_Donormil.; Артюхова М.Г., Шанаева И.А. Структура и особенности лечения нарушений сна у больных сердечно-сосудистыми заболеваниями. РМЖ. 2010;(26):1573. Режим доступа: https://www.rmj.ru/articles/nevrologiya/Struktura_i_osobennosti_lecheniya_narusheniy_sna_u_bolynyh_serdechnososudistymi_zabolevaniyami.; Садовникова И.И. Проблема инсомнии в практике кардиолога. РМЖ. 2006;(10):770. Режим доступа: https://www.rmj.ru/articles/obshchiestati/Problema_insomnii_v_praktike_kardiologa.; Бурчаков Д.И. Доксиламин и мелатонин в коррекции нарушений сна в гинекологической практике. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;118(4–2):67–72. https://doi.org/10.17116/jnevro20181184267.; Мельников А.Ю., Лаврик С.Ю., Бикбулатова Л.Ф., Рагинене И.Г., Иванова Я.А., Захаров А.В. Эффективность препарата реслип (доксиламин) при острой инсомнии: многоцентровое открытое сравнительное рандомизированное исследование. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017;117(4–2):56–59. https://doi.org/10.17116/jnevro20171174256-59.; Кочергина О.С., Рахматуллина Э.Ф., Губеев Б.Э. Нарушения сна и их коррекция у пациентов с хронической болью в спине. Медицинский совет. 2021;(19):201–207. https://doi.org/10.21518/2079-701X-2021-19-201-207.; Девликамова Ф.И., Хайбуллина Д.Х. Персонализированный подход к лечению инсомнии у пациентов с хронической болью в спине. Медицинский совет. 2022;(21):120–126. https://doi.org/10.21518/2079701X-2022-16-21-120-126.; Ващенко Н.В., Кожев А.И., Азимова Ю.Э. Нарушения сна при мигрени. Медицинский совет. 2021;(2):111–120. https://doi.org/10.21518/2079701X-2021-2-111-120.; Choi D.W., Chun S.Y., Lee S.A., Han K.T., Park E.C. Association between Sleep Duration and Perceived Stress: Salaried Worker in Circumstances of High Workload. Int J Environ Res Public Health. 2018;15(4):796. https://doi.org/10.3390/ijerph15040796.; Santos M.S., Ferreira F., Cunha A.P., Carvalho A., Macedo T. An aqueous extract of valerian influences the transport of GABA in synaptosomes. Planta Medica. 1994;60(3):278–279. https://doi.org/10.1055/s-2006-959476.; https://www.med-sovet.pro/jour/article/view/7416